Genoa, Italy

Alessio De Simone

This inventor holds 1 USPTO granted patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, University of California. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessio De Simone. Retrieved from https://idiyas.com/inventor/alessio-de-simone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alessio De Simone: Innovator in Pharmacology

Introduction

Alessio De Simone is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific enzymes and receptors in the human body. His work has implications for various therapeutic applications.

Latest Patents

Alessio De Simone holds a patent for "Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)." This invention provides compounds of Formula (I) or pharmaceutically acceptable salts thereof, which are crucial for advancing medical treatments.

Career Highlights

Throughout his career, Alessio has worked with prestigious institutions, including the Fondazione Istituto Italiano Di Tecnologia and the University of California. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Alessio has collaborated with notable colleagues such as Giovanni Bottegoni and Gian Filippo Ruda. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Alessio De Simone is a distinguished inventor whose work in pharmacology continues to influence the development of innovative therapeutic solutions. His contributions are vital to advancing our understanding of enzyme inhibitors and receptor modulators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…